Pecan Biotherapeutics Brochure - Click here to download
Campbell, GR, & Loret E., P. (2009)

What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology, 6, 50-63.

Watkins, J., Campbell, G.R., Halimi, H. & Loret, E.P. (2008)

Homonuclear 1H NMR and Circular Dichroism Study of the HIV-1 Tat Eli variant. Retrovirology 5, 83-94.

Campbell GR, Senkaali D, Watkins J, Esquieu D, Opi S, Yirrell DL, Kaleebu P, Loret EP. (2007)

Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties. Vaccine 25, 8441-17.

Watkins, J., Esquieu, D., Campbell, G.R., Lancelot, S., de Mareuil, J., Opi, S., Annappa, S., Salles, J.P. & Loret, E.P. (2006)

Reservoir Cells no longer Detectable after a Heterologous SHIV Challenge with the Synthetic HIV-1 Tat Oyi Vaccine. Retrovirology 3, 8-18.

Campbell, G.R., Pasquier, E., Watkins, J., Bourgarel-Rey, V., Peyrot, V., Esquieu, D., Barbier, P., de Mareuil, J., Braguer, D., Kaleebu, P., Yirrell, D. Y., & Loret, E. P. (2004)

The Glutamine-Rich Region of HIV-1 Tat Protein Involved in T-Cell Apoptosis J. Biol. Chem. 279, 48197-48204.

Opi, S., Péloponèse, J.M, Esquieu, D., Watkins, J., Campbell, G., de Mareuil, J., Jeang, K.T., Yirrell, D., Kaleebu, P. & Loret, E.P. (2004)

Full-length HIV-1 Tat protein Necessary for a Vaccine. Vaccine 22, 3105-3111.

Opi, S., Péloponèse, J.M., Esquieu, D., Campbell, G., de Mareuil, J., Walburger, A., Solomiac, M., Grégoire, C., Bouveret, E., Yirrell , DE, & Loret., EP (2002)

Tat HIV-1 Primary And Tertiary Structures Critical To Immune Response Against Non-Homologous Variants. J. Biol. Chem. 277, 35915-35919.

Péloponèse, J. M., Grégoire, C., Opi, S., Esquieu, D., Sturgis, J., Lebrun, E., Meurs, E., Collette, Y., Olive, D., Aubertin, A.M., Witvrow, M., Pannecouque, C., De Clercq, E., Bailly, C., Lebreton, J. & Loret. E. P. (2000)

1H-13C Nuclear Magnetic Resonance Assignment And Structural Characterization of HIV-1 Tat Protein. C. R. Acad. Sci. 323, 883-894.

Péloponèse, J.-M., Collette, Y., Gregoire, C., Bailly, C., Campèse, D., Meurs, E., Olive, D., & Loret, E. P. (1999)

Full peptide synthesis, purification and characterization of six Tat variants: differences observed between HIV-1 isolates from Africa and other continents. J. Biol. Chem. 274, 11473-11479.

Gregoire, C. & Loret, E. P. (1996)

Conformational Heterogeneity in Two Regions of TAT Results in Structural Variations of this Protein as a Function of HIV-1 Isolates. J. Biol. Chem. 271, 22641-22646.

Loret, E. P., Georgel, P., Johnson, W. C., & Ho, P. S. (1992)

Structural Changes in the Binding Region of Tat Complexed with HIV-1 TAR RNA : Vacuum UV Circular Dichroism and Molecular Modeling Studies. Proc. Natl. Acad. Sci. USA 89, 9734-9738.

Loret, E.P., Vives, E., Ho, P. S., Rochat, H., Van Rietschoten, J., & Johnson, W.C.(1991)

Activating Region of HIV-1 Tat Protein: Vacuum UV Circular Dichroism and Energy Minimization. Biochemistry 30, 6013-6023.